TMFMassimo’s Activity

Yesterday

NL

Article

TMFMassimo published an article 7:30 PM

Allergan, Inc.: Another Billion-Dollar Buyout Target

Valeant might continue its acquisition streak with the hefty purchase of Allergan.

Thu Apr 10

NL

Article

TMFMassimo published an article 10:04 AM

Biotech Banter: FDA Delay, Clinical Trial News, and Tweet of the Week

The latest from The Motley Fool's biotech show "Biotech Banter."

Mon Mar 31

Article Comment

TMFMassimo commented on an article. 10:12 AM

Better Chance of Making a Comeback: Amarin plc or VIVUS, Inc.?

@dontworrycmurray, thank you for pointing out this oversight. It has been corrected along with an editor's note.

Fri Mar 28

NL

Article

TMFMassimo published an article 11:02 AM

An Interview With Portola Pharmaceuticals CEO Bill Lis

Motley Fool analyst Max Macaluso discusses Portola Pharmaceuticals' pipeline and approach to research and development with CEO Bill Lis.

Mon Mar 24

NL

Article

TMFMassimo published an article 12:00 PM

Better Buy: CONSOL Energy vs. Gilead Sciences

We've collected the most popular companies among Fool.com readers and put them head-to-head in a good old-fashioned challenge we're calling The Motley Fool Better-Buy Tournament.

Sat Mar 22

NL

Article

TMFMassimo published an article 10:00 AM

Better Buy: Gilead Sciences vs. Berkshire Hathaway

We've collected the most popular companies amongst Fool.com readers and put them head-to-head in a good old-fashioned challenge we're calling The Motley Fool's Better Buy Tournament.

Fri Mar 21

NL

Article

TMFMassimo published an article 12:00 PM

Better Buy: Enterprise Products Partners vs. Amgen

We've collected the most popular companies amongst Fool.com readers and put them head-to-head in a good old-fashioned challenge we're calling The Motley Fool Better-Buy Tournament.

Wed Mar 19

NL

Article

TMFMassimo published an article 3:59 PM

Ranking Big Pharma's Top Drugs of 2013

Ranking the pharma industry's three biggest winners of 2013.

Tue Mar 18

NL

Article

TMFMassimo published an article 4:00 PM

Better Buy: Netflix vs. Gilead Sciences

We've collected the most popular companies amongst Fool.com readers and put them head-to-head in a good old-fashioned challenge we're calling The Motley Fool Better-Buy Tournament.

Sun Mar 16

NL

Article

TMFMassimo published an article 4:15 PM

3 Prescription Drugs You Didn't Know Come From Marijuana

A close look at three prescription drugs you probably didn't know come from one of the world's most controversial plants: cannabis.

Wed Mar 5

Article Comment

TMFMassimo commented on an article. 10:27 AM

Can Abbott Laboratories Beat Baxter International and Edwards Lifesciences in 2014?

@klebad, @PEStudent,

Thanks for catching this error, we'll make a correction.

Tue Mar 4

NL

Article

TMFMassimo published an article 6:30 PM

The Spark of Innovation at Vertex Pharmaceuticals Incorporated

Motley Fool analyst Max Macaluso discusses how Vertex Pharmaceutical's culture helped the company develop break-through medications with author Barry Werth.

Mon Mar 3

NL

Article

TMFMassimo published an article 9:37 AM

4 Keys to Vertex Pharmaceuticals' Success

Motley Fool analyst Max Macaluso discusses the keys to Vertex Pharmaceuticals' success with Barry Werth, author of "The Antidote: Inside the World of New Pharma."

Thu Feb 27

NL

Article

TMFMassimo published an article 5:31 PM

Ask a Fool: What Is Your Foolish Opinion of Horizon Pharma?

Here's one analyst's Foolish take on this explosive biotech stock.

NL

Article

TMFMassimo published an article 4:25 PM

From Startup to Billion-Dollar Biotech: An Inside Look at Vertex Pharmaceuticals

An interview with Barry Werth, author of "The Antidote: Inside the World of New Pharma."

Thu Feb 13

NL

Article

TMFMassimo published an article 1:45 PM

Marijuana Stocks: A Real Investing Opportunity or Not Worth the Hype?

There has been a lot of hype around marijuana stocks lately, but is this market too immature to invest in today?

Tue Feb 11

NL

Article

TMFMassimo published an article 9:30 AM

Dividend Stock To Watch Today: Sanofi

This is why investors should get Sanofi on their watchlist.

Tue Feb 4

NL

Article

TMFMassimo published an article 4:18 PM

Medicine and Gaming: The Surprising Link You (Probably) Don't Know About

The worlds of medicine and gaming aren't as far apart as you might think.

Mon Feb 3

NL

Article

TMFMassimo published an article 6:30 PM

AstraZeneca Stock: 1 Red Light, 1 Green Light

One pro and one con for investors looking at AstraZeneca today.

Fri Jan 31

NL

Article

TMFMassimo published an article 6:45 PM

Can Teva Rebound After This Rejection?

Teva got some very bad news last week. Will the company be able to bounce back?

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating < 20
Player Rank 0 out of 74855
Score 0.00
Score Change Today -47.16
Accuracy 0.00%
Active Picks 6
Total Picks 14
Best Pick TARO (+137.55)
Worst Pick OSUR (-76.63)
Average Score per Pick 10.99
Charms Earned 1
Highest Rated Favorite No Favorites Selected
Go to TMFMassimo’s CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show TMFMassimo’s 10 Latest Posts